NBRV - Nabriva Therapeutics' (NBRV) CEO Ted Schroeder on Q4 2019 Results - Earnings Call Transcript
Nabriva Therapeutics PLC (NBRV)
Q4 2019 Earnings Conference Call
March 12, 2020 4:30 PM ET
Company Participants
Gary Sender – Chief Financial Officer
Ted Schroeder – Chief Executive Officer
Francesco Maria Lavino – Chief Commercial Officer
Steve Gelone – President and Chief Operating Officer
Conference Call Participants
David Lebowitz – Morgan Stanley
Alan Carr – Needham & Co
Kevin Kedra – G.Research
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Nabriva Fourth Quarter 2019 Financial Results Call. At this time, all participants are in a listen-only mode. Later, we will conduct a